Multifocal pyoderma gangrenosum resistant to infliximab in active ulcerative colitis: don't forget the role of cyclosporin

Inflamm Bowel Dis. 2012 Aug;18(8):E1594-5. doi: 10.1002/ibd.21915. Epub 2011 Oct 29.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / adverse effects*
  • Colitis, Ulcerative / complications
  • Colitis, Ulcerative / drug therapy*
  • Cyclosporine / therapeutic use*
  • Dermatologic Agents / adverse effects*
  • Drug Resistance / drug effects*
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Infliximab
  • Prognosis
  • Pyoderma Gangrenosum / chemically induced*
  • Pyoderma Gangrenosum / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Dermatologic Agents
  • Immunosuppressive Agents
  • Cyclosporine
  • Infliximab